CONTEXT: Studies examining whether vitamin D supplementation increases muscle mass or muscle-specific vitamin D receptor (VDR) concentration are lacking. OBJECTIVE: Our objective was to determine whether vitamin D₃ 4000 IU/d alters muscle fiber cross-sectional area (FCSA) and intramyonuclear VDR concentration over 4 months. DESIGN AND SETTING: This was a randomized, double-blind, placebo-controlled study in a single center. PARTICIPANTS: Participants were 21 mobility-limited women (aged ≥ 65 years) withserum 25-hydroxyvitamin D (25OHD) levels of 22.5 to 60 nmol/L. MAIN OUTCOME MEASURES: Baseline and 4-month FCSA and intramyonuclear VDR were measured from vastus lateralis muscle cross-sections probed for muscle fiber type (I/IIa/IIx) and VDR using immunofluorescence. RESULTS: At baseline, mean (±SD) age was 78 ± 5 years; body mass index was 27 ± 5 kg/m², 25OHD was 46.3 ± 9.5 nmol/L, and a short physical performance battery score was 7.95 ± 1.57 out of 12. At 4 months, 25OHD level was 52.5 ± 17.1 (placebo) vs 80.0 ± 11.5 nmol/L (vitamin D [VD]; P < .01), and change in 25OHD level was strongly associated with percent change in intramyonuclear VDR concentration-independent of group (r = 0.87, P < .001). By treatment group, percent change in intramyonuclear VDR concentration was 7.8% ± 18.2% (placebo) vs 29.7% ± 11.7% (VD; P = .03) with a more pronounced group difference in type II vs I fibers. Percent change in total (type I/II) FCSA was -7.4% ± 18.9% (placebo) vs 10.6% ± 20.0% (VD; P = .048). CONCLUSION:Vitamin D₃ supplementation increased intramyonuclear VDR concentration by 30% and increased muscle fiber size by 10% in older, mobility-limited, vitamin D-insufficient women. Further work is needed to determine whether the observed effect of vitamin D on fiber size is mediated by the VDR and to identify which signaling pathways are involved.
RCT Entities:
CONTEXT: Studies examining whether vitamin D supplementation increases muscle mass or muscle-specific vitamin D receptor (VDR) concentration are lacking. OBJECTIVE: Our objective was to determine whether vitamin D₃ 4000 IU/d alters muscle fiber cross-sectional area (FCSA) and intramyonuclear VDR concentration over 4 months. DESIGN AND SETTING: This was a randomized, double-blind, placebo-controlled study in a single center. PARTICIPANTS: Participants were 21 mobility-limited women (aged ≥ 65 years) with serum 25-hydroxyvitamin D (25OHD) levels of 22.5 to 60 nmol/L. MAIN OUTCOME MEASURES: Baseline and 4-month FCSA and intramyonuclear VDR were measured from vastus lateralis muscle cross-sections probed for muscle fiber type (I/IIa/IIx) and VDR using immunofluorescence. RESULTS: At baseline, mean (±SD) age was 78 ± 5 years; body mass index was 27 ± 5 kg/m², 25OHD was 46.3 ± 9.5 nmol/L, and a short physical performance battery score was 7.95 ± 1.57 out of 12. At 4 months, 25OHD level was 52.5 ± 17.1 (placebo) vs 80.0 ± 11.5 nmol/L (vitamin D [VD]; P < .01), and change in 25OHD level was strongly associated with percent change in intramyonuclear VDR concentration-independent of group (r = 0.87, P < .001). By treatment group, percent change in intramyonuclear VDR concentration was 7.8% ± 18.2% (placebo) vs 29.7% ± 11.7% (VD; P = .03) with a more pronounced group difference in type II vs I fibers. Percent change in total (type I/II) FCSA was -7.4% ± 18.9% (placebo) vs 10.6% ± 20.0% (VD; P = .048). CONCLUSION:Vitamin D₃ supplementation increased intramyonuclear VDR concentration by 30% and increased muscle fiber size by 10% in older, mobility-limited, vitamin D-insufficient women. Further work is needed to determine whether the observed effect of vitamin D on fiber size is mediated by the VDR and to identify which signaling pathways are involved.
Authors: Heike A Bischoff-Ferrari; Thomas Dietrich; E John Orav; Frank B Hu; Yuqing Zhang; Elisabeth W Karlson; Bess Dawson-Hughes Journal: Am J Clin Nutr Date: 2004-09 Impact factor: 7.045
Authors: Lisa Ceglia; Mauricio da Silva Morais; Lara K Park; Evan Morris; Susan S Harris; Heike A Bischoff-Ferrari; Roger A Fielding; Bess Dawson-Hughes Journal: J Mol Histol Date: 2010-06-13 Impact factor: 2.611
Authors: Heike A Bischoff; Hannes B Stähelin; Walter Dick; Regula Akos; Margrith Knecht; Christian Salis; Matthias Nebiker; Robert Theiler; Michael Pfeifer; Bettina Begerow; Robert A Lew; Martin Conzelmann Journal: J Bone Miner Res Date: 2003-02 Impact factor: 6.741
Authors: Natalia O Kuchuk; Saskia M F Pluijm; Natasja M van Schoor; Caspar W N Looman; Johannes H Smit; Paul Lips Journal: J Clin Endocrinol Metab Date: 2009-01-21 Impact factor: 5.958
Authors: O Meyer; B Dawson-Hughes; E Sidelnikov; A Egli; D Grob; H B Staehelin; G Theiler; R W Kressig; H P Simmen; R Theiler; H A Bischoff-Ferrari Journal: Osteoporos Int Date: 2014-11-05 Impact factor: 4.507
Authors: Julie Shlisky; David E Bloom; Amy R Beaudreault; Katherine L Tucker; Heather H Keller; Yvonne Freund-Levi; Roger A Fielding; Feon W Cheng; Gordon L Jensen; Dayong Wu; Simin N Meydani Journal: Adv Nutr Date: 2017-01-17 Impact factor: 8.701
Authors: Monirah M Almurdhi; Neil D Reeves; Frank L Bowling; Andrew J M Boulton; Maria Jeziorska; Rayaz A Malik Journal: Diabetes Care Date: 2016-01-06 Impact factor: 19.112